These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8525713)

  • 1. Concomitant natural infection with L. donovani and L. major: a case report from Iraq.
    al-Diwany LJ; al-Awkati NA; Atia M; Rassam MB
    Soz Praventivmed; 1995; 40(4):234-8. PubMed ID: 8525713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization.
    Mebrahtu YB; Lawyer PG; Hendricks LD; Muigai R; Oster CN; Perkins PV; Koech DK; Pamba H; Roberts CR
    Am J Trop Med Hyg; 1991 Sep; 45(3):290-6. PubMed ID: 1928563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of Leishmania major and Leishmania donovani in southern Turkey.
    Koltas IS; Eroglu F; Alabaz D; Uzun S
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):154-8. PubMed ID: 24449479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection.
    Zhang WW; Mendez S; Ghosh A; Myler P; Ivens A; Clos J; Sacks DL; Matlashewski G
    J Biol Chem; 2003 Sep; 278(37):35508-15. PubMed ID: 12829719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. donovani versus heterogeneity of L. major.
    Ibrahim ME; Evans DA; Theander TG; el Hassan AM; Kharazmi A
    Trans R Soc Trop Med Hyg; 1995; 89(4):366-9. PubMed ID: 7570863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana.
    Zakai HA; Chance ML; Bates PA
    Parasitology; 1998 Apr; 116 ( Pt 4)():305-9. PubMed ID: 9585932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Leishmania donovani and L. tropica in Ethiopian wild rodents.
    Kassahun A; Sadlova J; Dvorak V; Kostalova T; Rohousova I; Frynta D; Aghova T; Yasur-Landau D; Lemma W; Hailu A; Baneth G; Warburg A; Volf P; Votypka J
    Acta Trop; 2015 May; 145():39-44. PubMed ID: 25700710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.
    Kariyawasam KKGDUL; Selvapandiyan A; Siriwardana HVYD; Dube A; Karunanayake P; Senanayake SASC; Dey R; Gannavaram S; Nakhasi HL; Karunaweera ND
    Parasitology; 2018 Apr; 145(4):443-452. PubMed ID: 29113609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.
    McCall LI; Zhang WW; Dejgaard K; Atayde VD; Mazur A; Ranasinghe S; Liu J; Olivier M; Nilsson T; Matlashewski G
    J Proteome Res; 2015 Feb; 14(2):1033-59. PubMed ID: 25536015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India.
    Srivastava P; Prajapati VK; Vanaerschot M; Van der Auwera G; Dujardin JC; Sundar S
    Infect Genet Evol; 2010 Oct; 10(7):1145-50. PubMed ID: 20633704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An imported case of cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Japan.
    Ito K; Takahara M; Ito M; Oshiro M; Takahashi K; Uezato H; Imafuku S
    J Dermatol; 2014 Oct; 41(10):926-8. PubMed ID: 25228325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior in a mouse model of isolates of Leishmania donovani sensu lato cultured from the blood of patients with chronic cutaneous lesions.
    Nuwayri-Salti N; Matta M; Shbaklo Z; Lakkis M; Kabbani ZE
    Am J Trop Med Hyg; 1998 Jun; 58(6):710-4. PubMed ID: 9660450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya.
    Mebrahtu YB; Van Eys G; Guizani I; Lawyer PG; Pamba H; Koech D; Roberts C; Perkins PV; Were JB; Hendricks LD
    Trans R Soc Trop Med Hyg; 1993; 87(5):598-601. PubMed ID: 8266420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody.
    Ismail A; Kharazmi A; Permin H; el Hassan AM
    Trans R Soc Trop Med Hyg; 1997; 91(3):283-5. PubMed ID: 9231195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
    Al-Abdely HM; Graybill JR; Loebenberg D; Melby PC
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2910-4. PubMed ID: 10582881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.
    Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC
    Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.